Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Brixton Metals Drills 15m of 2.26 g/t Gold at the Trapper Gold Target
-
FinWise Bancorp to Host Third Quarter 2025 Earnings Conference Call and Webcast on Wednesday, October 29, 2025
-
Sampo plc: Managers’ Transactions (Talasmäki)
-
Sampo plc: Managers’ Transactions (Wennerklint)
-
Sampo plc: Managers’ Transactions (Magnusson)
-
Sampo plc: Managers’ Transactions (Thorsrud)
-
Sampo plc: Managers’ Transactions (Janbu Holthe)
-
Sampo plc: Managers’ Transactions (Alsaker)
-
Sampo plc: Managers’ Transactions (Svensson)
-
Nexxen Announces September 2025 Share Repurchase Program Summary
-
Aclarion Presents at LSI Europe ’25 Highlighting Nociscan Technology and Key Value Drivers
-
Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01
-
Cash Flows
-
$1000 Quick Loan No Credit Check: RadCred Launches AI-Powered Platform for Instant Payday Loan Online for Bad Credit in 2025
-
Plug Power Delivers First Electrolyzer for 100MW Green Hydrogen Project at Galp’s Sines Refinery
-
XRP Tundra Confirms Phase 4 Presale Bonuses and Free Governance Token Allocation
-
Form 8.3 - AXA INVESTMENT MANAGERS: Unite Group plc
-
Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
-
Spur Therapeutics to Present New Clinical Data on Its Gene Therapy Candidate in Gaucher Disease at Upcoming ESGCT Annual Congress
-
Comphya Announces First Patient Implanted with CaverSTIM in U.S. Pilot Study at Johns Hopkins University School of Medicine
-
Arvinas to Present Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
-
BioCryst Completes Sale of European ORLADEYO® (berotralstat) Business
-
Black Diamond Group Limited Announces Timing for Third Quarter 2025 Financial Results and Conference Call
-
Guardian Capital Group Limited Provides Shareholders with Update Regarding the Delivery of its Special Meeting Materials in Light of Canada Post National Labour Strike
-
Apollo Silver Announces $20.88 Million Private Placement Offering
-
Gaming and Leisure Properties to Acquire Sunland Park Racetrack & Casino Real Estate Assets
-
Caliber Appoints Blake Janover to Crypto Advisory Board
-
Uber Freight Appoints D'Andrae Larry as Chief Commercial Officer to Lead Unified Commercial Organization
-
Neumora Therapeutics to Host Virtual R&D Day on October 27
-
Aerska Launches with $21 Million in Financing to Develop RNAi Medicines for Diseases of the Brain
-
OCS to Deliver £2.4m Solar Carport at Scottish Water’s Head Office in Partnership with Scottish Water Horizons
-
Chijet Motor Company Secures Commitment to Expand Private Placement to $1 Billion Following Strong Investor Demand
-
Medicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
-
Liver Cancer Rates Continue to Rise - Know Your Risks
-
Verano Secures US $75,000,000 Revolving Credit Facility
-
Uber Freight Appoints D'Andrae Larry as Chief Commercial Officer to Lead Unified Commercial Organization
-
Multiple Myeloma Research Foundation Unites Patients and Advocates to Hike New Hampshire’s White Mountains to Accelerate a Cure for Multiple Myeloma
-
PyroGenesis Announces Non-Brokered Private Placement
-
Urticaria Day: Raising Awareness of Symptoms and Treatment
-
Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources
-
Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer
-
Regenx Announces Issuance of Cease Trade Order
-
C4 Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Pfizer for the Combination of Cemsidomide and Elranatamab for the Treatment of Relapsed/Refractory Multiple Myeloma
-
Sagimet Biosciences Announces Dosing of First Participants in Phase 1 PK Clinical Trial for Denifanstat and Resmetirom Combination
-
Finprime.pro Secures DASP License from El Salvador’s CNAD, Strengthening Commitment to Compliance and Security in Digital Assets
-
Close-Up International Selected by VS Health Group to Deliver Market Access Business Intelligence CRM Solution
-
Climb Channel Solutions Launches North American Partnership with Binary Defense to Deliver Attacker-Minded MDR Solutions
-
Accumulus Synergy Appoints Khushboo Sharma as Chief Executive Officer
